Last update Dec. 1, 2004

Foscarnet

High Risk

Poorly safe. Evaluate carefully. Use safer alternative or interrupt breastfeeding 3 to 7 T ½ (elimination half-lives). Read the Comment.

No untoward effect has been described but it has shown to be toxic to the kidney, a cause of seizures, and may be stored in bones and teeth.

Alternatives

We do not have alternatives for Foscarnet.

Suggestions made at e-lactancia are done by APILAM team, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it.

Jose Maria Paricio, Founder & President of APILAM/e-Lactancia

Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.

Thank you for helping to protect and promote breastfeeding.

José María Paricio, founder of e-lactancia.

Group

Foscarnet belongs to this group or family:

Tradenames

Main tradenames from several countries containing Foscarnet in its composition:

Pharmacokinetics

Variable Value Unit
Oral Bioavail. 21 %
Molecular weight 192 daltons
Protein Binding 14 %
Tmax 0,01 hours
T1/2 3 hours
M/P ratio 3 -

References

We are working to add the scientific references of this product. It will be available soon. If you wish to have access to this information, please let us know by leaving your comment in the opinion section below.

Total visits

2,350

Help us improve this entry

How to cite this entry

Do you need more information or did not found what you were looking for?

   Write us at elactancia.org@gmail.com

e-lactancia is a resource recommended by IHAN of Spain

Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM